Luminary Group’s Post

Zuellig Pharma was honoured to be a part of the 2024 Annual J.P. Morgan Healthcare Conference in San Francisco last week, the largest and most informative healthcare investment symposium in the industry connecting over 8,000 global industry leaders, executives and investors. With an optimistic outlook for 2024, conversations centred around the future of healthcare fuelled by an improving global economy, rising merger and acquisition activity, biopharmas’ increasing focus on key therapeutic areas such as obesity, a growing interest in China and the FDA’s focus on artificial intelligence and data and enterprise transformation.   Our Group CEO John A. Graham shared key insights on the growing Southeast and North Asia region, which represents the world’s third-largest market with a population of 1 billion people, before diving into how Zuellig Pharma connects biopharma companies, healthcare professionals, patients and consumers across the healthcare value chain in the region. In particular, he shed light on how Zuellig Pharma builds strategic commercial partnerships to support companies in attaining market leadership in key therapeutic areas, and leverages technology for our innovative market-leading digital tools and support programmes.   As a leading integrated healthcare solutions company, Zuellig Pharma powers the healthcare ecosystem through our wide range of solutions, from commercialisation and market expansion, distribution, clinical trials and sourcing to contract manufacturing. We look forward to deepening existing strategic partnerships and striking up new collaborations with multinational healthcare leaders in 2024, as we remain focused on our mission of making healthcare more accessible in Asia.   #JPMHC24 #HealthcareTrends #MakingHealthcareMoreAccessible 

For HealthTech companies trying to navigate working with Pharma … I’m inviting you to a 60min open Q&A on June 7th where I’ll share my experience as a ex-pharma global digital leader (and fulfill a promise I made after LSX World congress last month 😀) … The format will be 20mins of insight sharing covering the typical questions I'm asked, followed by an "ask me anything" Q&A. Specifically, I’ll aim to cover: 1) Pharma org structures – who does what? (R&D, Commercial, BD, CVC, CSR, Franchises, Regions, Countries) 2) What makes a compelling HealthTech / Pharma value proposition? (Technologies, people, relationships, therapeutic expertise, efficacy, footprint, vision) 3) “Voice of the corporate customer” How to get started? (Intro emails, navigating, referrals, marketing, events / conferences, NDA/CDA) If you're interested to join this or future sessions, either comment below or message me. Thanks Mauricio Karam for the suggestion :) PS I noticed the CET time conversion in the image is wrong ... the correct timing is June 7th - 8-9am EST / 1-2pm UK / 2-3pm CET #healthtech #digitalhealth #innovation #commercialinnovation #healthcare #pharma #nexterahealth #10xhealth #partnerships

Are you currently working in an agency setting and contemplating a career shift into the pharmaceutical industry? If so, this promises to be a helpful webinar. Having made this switch myself, I can personally attest to the value agency experience brings to the #pharma sector. I’m eager to hear if others share similar experiences and to discuss how this pivotal career move can be made successfully. #medcomms #careerchange

Technology continues to revolutionize the field of medicine, propelling us towards more personalized and efficient patient care. Digital Health solutions including Telehealth have significantly changed the landscape, enabling healthcare providers to connect with patients regardless of geographical boundaries, ensuring that high-quality care is accessible to everyone. Innovations in Digital Health signal a future where medical care is not only more inclusive but also more proactive in addressing patient needs. My upcoming panel at @Future Pharma titled ""The Benefits of Digital/ Telehealth and How Pharma Can Lead the Way in Delivering Exceptional Care"" on June 26th will discuss the power of digital health in improving patient outcomes. I will speak to the future of medicine as I share insights on how pharma companies can leverage digital health to truly deliver top-notch care to patients - from meeting the patient where they are, to collecting insights based on patient interactions. My panelists, Jackie S. Zou, MBA Zou (Myriad Genetics), Stephen Framil (Merck), and I will seek to answer one major question: How can pharma truly deliver benefits to its patients through digital health channels? #FuturePharma #TelehealthRevolution #FutureofHealthcare

Bain & Company's M&A report is here and paints an interesting picture for the healthcare & life sciences industry. A few observations: 1. A headline takeaway is that in the coming years players in the industry need to invest in disruptive technologies to set themselves apart from competition and adapt their business models.  2. #Pharma dominated the landscape with large deals thanks to their strong cash positions which caused the industry as a whole to see an uptick in 2023 deal value.  3. #Medtech was a similar story to pharma, but on a smaller scale with a few large deals accounting for a larger deal value, but lower volume than in past years.  4. #Payers, #providers, and #healthservices had a slower year, but these entities are focusing on targets that allow them to provide better care and scale in primary care, home health, and facility care (a strong example of this is the CVS Health/Oak Street Health deal).  5. Scope deals dominated the type of deals conducted at 89% suggesting healthcare and life science companies are continuing ambitions to enter new markets. Read more here: https://lnkd.in/eRtRCDeE 

In the dynamic world of #Healthcare and #Sales, traditional models might not always cut it. Gaurav Khandelwal, Director, Pharma & Consumer Healthcare Business, Docquity, believes a revamped thought process in sales team structure is crucial, especially with Key Account Management in the picture. On the other hand, Pushkar Singh, Senior Director, Rare Disease BU, Novo Nordisk, underlines that our sales and organizational blueprints should inherently mirror our business objectives. Check out more expert insights from RAINGroup's roundtable, Unlocking KAM in Healthcare Sales.: https://lnkd.in/dWTiFAtX

🚀 Exciting times ahead for HEOR leaders in biopharma! As we navigate the evolving landscape of evidence generation and synthesis, it's crucial to address the top data challenges head-on. From data quality to privacy, these hurdles can hinder progress and innovation. 🎯 Enter the integrated evidence platform - a game-changer in overcoming these challenges! By integrating diverse data sources, this platform ensures data quality and reliability. It also streamlines access and integration, allowing for a comprehensive view of real-world data while maintaining privacy and compliance. 🔍 With standardized data formats and advanced analytics, the platform enables robust analysis and interpretation, turning complex datasets into actionable insights. Moreover, by keeping pace with technological advancements, it ensures that HEOR leaders are always at the forefront of innovation. 💡 The result? A transformative approach to evidence generation and synthesis, empowering HEOR leaders to make informed decisions that drive meaningful outcomes. Let's embrace the future of healthcare together with integrated evidence platforms! #HEOR #EvidenceGeneration #Biopharma

🤝You want to partner with #Pharma in #DigitalHealth⁉️See👇 Few hints from Pharma leaders #LIVE from HLTH Europe: Stephen R. Malin Johansson Lisa Banks, PhD, MBA. Aquil Harjivan moderated by Anish Shindore (just arrived by 🚴). None of the panelists wants to crack digital health alone 🎉🥳👏 BUT you should: 👉 Understand the real problem you try to tackle first (Malin) 👉 Who is the decision maker at Pharma? Ask upfront and find the right contact to partner with (Malin) 👉 Understand where the Pharma organization is in terms of readiness and try to bring the cross-functional team along (Stephen) 👉 There is a lot of back and forth discussions and piloting between Pharma and ventures („Teenage love affair“) (Lisa) …but at some point you either „marry“ or „break-up“ (my personal addition to the bullet) 👉 Do your homework, understand how Pharma operates, what the challenges are before you reach out (Stephen and Lisa) 👉Do not overpromise - Stay true to the real value of your product - what is working and what not (Stephen) 👉 Partnership require also sharing the risk of being not successful. Are risk-sharing business models an option ? (Malin) Message conveyed 👍

👩🏻💻 On May 6th, I hosted a webinar for healthcare corporate leaders in collaboration with Niklas from @PeakSpirit. This webinar was on creating a credible market research and validation for healthcare companies. This main topic was based on my 20 years experience and the insights from more than 500 healthcare teams coached including ROCHE, ASTRAZENECA, MSD or PFIZER. 👩🏻🏫 We covered many subtopics, including: How to be clear for credible market research and validation using my MOBA technique; The 5 levels of evidence necessary to ensure the efficacy and market viability of your healthcare products or services; Cultivating the right mindset to gather high-quality data that creates desirability for your product or service; How to find users to know more about them and to develop desirable healthcare offerings; How to not be fooled when interpreting users feedbacks; How to use users feedback to improve your healthcare products or services. 💬 If you want to discover all the topics we covered during this webinar, comment "BAMBOOSTER" and I will send you the recording. 🙏🏻 Thanks again @Niklas, @Peter, @Alexander and the two other people (who will recognize themselves ;)) for joining me for this special webinar! - 🙋🏻♀️ Hi, my name is Aurélie! I help corporate leaders and healthcare teams to reduce the time between idea discovery and first customers. 📧 Boost your healthcare business in my newsletter: https://lnkd.in/ewKKfJ6R #innovation #digitalhealth #healthcare #medtech #biotech #bigpharma

A short insight into what you can expect from me as your partner of choice, what I find special about the MedTech space and why I chose to join the incredible Leaders in Care team. If you’re a business looking for extra resource in the upcoming months or, you would like to share perspectives & advice on today's market then let’s connect and chat about we can align with your recruitment strategy and add value to your business. Likewise, if you’re a professional looking to add another channel to your job search, receive real-time market advice and guaranteed added value to your chances of success in your next interview process. Pop over a message or send me an email and let’s arrange an open conversation. 📧jody@leadersincare.co.uk